Hyosung Chemical Corporation (KRX:298000)
South Korea flag South Korea · Delayed Price · Currency is KRW
38,900
-1,150 (-2.87%)
Feb 28, 2025, 3:30 PM KST

Hyosung Chemical Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
2,354,8142,340,7182,452,2202,623,2692,878,5582,519,965
Other Revenue
0000--0
2,354,8142,340,7182,452,2202,623,2692,878,5582,519,965
Revenue Growth (YoY)
-3.76%-4.55%-6.52%-8.87%14.23%38.67%
Cost of Revenue
2,379,6152,411,2162,534,7252,731,1183,108,7142,282,689
Gross Profit
-24,801-70,498-82,505-107,849-230,156237,276
Selling, General & Admin
59,10664,30171,33078,89877,47973,583
Research & Development
15,47616,96319,09718,61820,88321,783
Amortization of Goodwill & Intangibles
511511524543541335
Other Operating Expenses
2,3742,3741,3581,4991,3341,380
Operating Expenses
83,32090,00392,305105,858106,571100,702
Operating Income
-108,121-160,500-174,810-213,707-336,727136,574
Interest Expense
-90,373-108,100-177,589-172,989-101,105-34,161
Interest & Investment Income
2,0122,1572,2033,3551,485209
Currency Exchange Gain (Loss)
-33,599-32,090-5,5052,048-18,023-10,515
Other Non Operating Income (Expenses)
-15,868-17,21510,852-7,2037,9099,741
EBT Excluding Unusual Items
-246,632-315,749-344,849-388,496-446,461101,848
Gain (Loss) on Sale of Investments
796.43796.43231.89-3,372-1,690325.81
Gain (Loss) on Sale of Assets
-600,139549-4,531-4,653-100198
Asset Writedown
-22,463-22,463----
Pretax Income
-868,438-336,866-349,148-396,520-448,251102,372
Income Tax Expense
-243,627-107,835-19,120-30,669-39,38443,956
Earnings From Continuing Operations
-624,811-229,031-330,029-365,851-408,86758,416
Earnings From Discontinued Operations
559,157555,0594,30418,938--
Net Income to Company
-65,654326,028-325,724-346,913-408,86758,416
Minority Interest in Earnings
79,12167,069----
Net Income
13,467393,098-325,724-346,913-408,86758,416
Preferred Dividends & Other Adjustments
17,55217,55212,7652,075--
Net Income to Common
-4,085375,545-338,490-348,988-408,86758,416
Net Income Growth
-88.99%-----
Shares Outstanding (Basic)
344333
Shares Outstanding (Diluted)
344333
Shares Change (YoY)
-19.20%-0.25%15.58%2.90%--
EPS (Basic)
-1322.8299614.53-89559.83-106720.55-128663.6718382.50
EPS (Diluted)
-1322.8299614.53-89559.83-106720.55-128663.6718382.50
Free Cash Flow
-206,966-128,968-230,373-65,247-378,605-259,605
Free Cash Flow Per Share
-67014.45-34209.19-60953.50-19952.53-119140.94-81693.38
Gross Margin
-1.05%-3.01%-3.36%-4.11%-7.99%9.42%
Operating Margin
-4.59%-6.86%-7.13%-8.15%-11.70%5.42%
Profit Margin
-0.17%16.04%-13.80%-13.30%-14.20%2.32%
Free Cash Flow Margin
-8.79%-5.51%-9.39%-2.49%-13.15%-10.30%
EBITDA
76,78322,60746,14331,564-48,851329,219
EBITDA Margin
3.26%0.97%1.88%1.20%-1.70%13.06%
D&A For EBITDA
184,904183,107220,953245,271287,876192,645
EBIT
-108,121-160,500-174,810-213,707-336,727136,574
EBIT Margin
-4.59%-6.86%-7.13%-8.15%-11.70%5.42%
Effective Tax Rate
-----42.94%
Advertising Expenses
-4606307061,008225